SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001328143-21-000034
Filing Date
2021-04-19
Accepted
2021-04-19 16:02:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A adms2021proxyadditionalmat.htm DEFA14A 21094
2 admsadditional11a.jpg GRAPHIC 518655
3 admsadditional21a.jpg GRAPHIC 343870
  Complete submission text file 0001328143-21-000034.txt   1209599
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36399 | Film No.: 21834573
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences